Substituted oxopyridine derivatives and use thereof as factor XIa/plasma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9918969
SERIAL NO

15332893

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTGERMANY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buchmüller, Anja Essen, DE 56 226
Gerdes, Christoph Köln, DE 68 313
Heitmeier, Stefan Wülfrath, DE 54 243
Hillisch, Alexander Solingen, DE 72 444
Röhrig, Susanne Hilden, DE 65 234
Schäfer, Martina Berlin, DE 39 170
Schlemmer, Karl-Heinz Wuppertal, DE 158 1353
Schmidt, Martina Victoria Köln, DE 23 39
Straβburger, Julia Wuppertal, DE 6 18
Teller, Henrik Schwaan, DE 20 51
Tersteegen, Adrian Wuppertal, DE 84 846

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00